057680 — T Scientific Co Balance Sheet
0.000.00%
- KR₩75bn
- KR₩71bn
- KR₩43bn
- 39
- 44
- 25
- 25
Annual balance sheet for T Scientific Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14,581 | 15,250 | 30,099 | 9,484 | 3,082 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 8,956 | 8,378 | 6,174 | 14,268 | 12,583 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28,840 | 30,898 | 45,728 | 31,037 | 22,563 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 620 | 518 | 2,342 | 1,513 | 2,183 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 108,716 | 296,285 | 262,538 | 173,981 | 163,268 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15,775 | 32,136 | 45,017 | 40,735 | 22,729 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 25,015 | 74,393 | 84,567 | 42,752 | 22,950 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 83,702 | 221,893 | 177,972 | 131,229 | 140,318 |
| Total Liabilities & Shareholders' Equity | 108,716 | 296,285 | 262,538 | 173,981 | 163,268 |
| Total Common Shares Outstanding |